pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·2d ago·1 min read
save

Rivia unveils AI-driven DataFindings module to accelerate clinical trial data cleaning, Scancell adopts early

Nov 9, 2026·read at Fierce Biotech ↗Positive

Swiss CRO Rivia introduced an AI-powered DataFindings module that integrates with its Rivia Core platform to automate continuous review of clinical trial data.

The tool uses AI agents to help users create data review rules, then monitors trial data for changes, flagging issues for attention and allowing task assignment with a full audit trail.

Rivia says the automation can reduce delays caused by unresolved data issues that slow the transition from trial completion to analysis and regulatory submission.

U.K.-based biotech Scancell serves as the design partner and first adopter of the new module.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “Rivia launches AI-powered clinical trial data review module, with Scancell as early adopter”

read at Fierce Biotech ↗
323 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
CRO/CDMO3Oncology

related stories

  • 7h agoNextCure nixes staffers before proposed mergerBioSpace
  • Sep 17DPHARM: How to address the clinical trial enrollment crisis?Fierce Biotech
  • Sep 17Biopharma hiring hotspots: States, disciplines where demand is highestBioSpace
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Sep 11Owkin, Servier ink oncology R&D deal to guide discovery and trial designFierce Biotech